CellRep
Founded 2024 · 2 known investors
CellRep uses AI to discover small molecules that rejuvenate immune cells without genetic modification, with a lead application enhancing CAR-T therapy against solid tumors. The compounds are applied ex vivo during manufacturing as reagents, building a platform for cellular rejuvenation spanning cancer immunotherapy and longevity.
AI & Machine LearningBiotechLongevity
Investors · 2
Frequently asked questions
- What does CellRep do?
- CellRep uses AI to discover small molecules that rejuvenate immune cells without genetic modification, with a lead application enhancing CAR-T therapy against solid tumors. The compounds are applied ex vivo during manufacturing as reagents, building a platform for cellular rejuvenation spanning cancer immunotherapy and longevity.
- Who are CellRep's investors?
- CellRep's investors include AIR Capital, GRIDX.